Products

Daylight
Big Health
Mental & Behavioral Health AI
Daylight is a digital care program for worry and anxiety—available anytime, anywhere. It offers tailored support and helps users track their progress with day-to-day practices and techniques for meaningful behavior change.

See all 1 product →

About Big Health

Big Health is a pioneering digital therapeutics company focused on delivering evidence-based, non-drug treatments for common mental health conditions such as insomnia, anxiety, and depression. Their flagship products, Sleepio and Daylight, utilize cognitive behavioral therapy (CBT) techniques delivered through digital platforms. These programs are designed to be scalable, accessible, and consistent, offering an alternative to traditional medication-based approaches. Big Health’s solutions are backed by rigorous research, including numerous peer-reviewed studies and randomized controlled trials, and are cited in leading clinical guidelines.

For physicians, Big Health’s offerings provide a valuable tool to address the significant demand for mental health support, especially given the challenges of access to in-person or teletherapy. The company’s digital therapeutics are FDA-cleared for certain conditions, such as SleepioRx for insomnia disorder and DaylightRx for generalized anxiety disorder, and are increasingly integrated into clinical workflows with established reimbursement pathways. Big Health partners with health systems, health plans, employers, and providers to offer these programs, aiming to improve outcomes, reduce healthcare costs, and expand access to care for diverse populations, including those traditionally underserved. They also recently expanded into adolescent mental health through the acquisition of Limbix and Freespira, addressing adolescent depression and panic disorders.

Focus Areas

digital therapeutics cognitive behavioral therapy (CBT) insomnia anxiety depression adolescent mental health digital mental health

Business Intelligence

Key InvestorsSoftBank Vision Fund 2, Kaiser Permanente Ventures, Index Ventures, 406 Ventures, AlleyCorp, CVS Health Ventures, Gilde Healthcare, Sandbox Industries, Supermoon Capital, The Blue Venture Fund, Octopus Ventures, Morningside Ventures
PartnershipsCVS Health, Grow Therapy, American Psychological Association, Henry Ford Health System, Oxford Health
AcquisitionsLimbix, Freespira
Technologycloud-native, digital behavioral medicine programs, AI operating system (implied by automated programs and personalized solutions)
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

Digital Therapeutics & CBT
Big Health specializes in digital therapeutics that deliver evidence-based Cognitive Behavioral Therapy (CBT) techniques. Their programs are fully automated and highly personalized, offering non-drug treatments for common mental health conditions.
Insomnia
Sleepio, Big Health's flagship product, is a digital sleep improvement program utilizing CBT for insomnia (CBTi). It has demonstrated high recovery rates and significant reductions in anxiety and depression symptoms in users.
Anxiety
Daylight is Big Health's digital treatment for worry and anxiety. Studies show that improvements in sleep through programs like Sleepio can significantly reduce anxiety symptoms.
Depression
Big Health offers SparkRx, a digital treatment for adolescent depression, acquired through Limbix. Their digital therapeutics, including Sleepio, have also shown to reduce symptoms of depression.
Adolescent Mental Health
With the acquisition of Limbix, Big Health expanded its portfolio to include SparkRx for adolescent depression and has an adolescent anxiety product in development, addressing the youth mental health crisis.
Key Differentiators
Big Health's competitive edge comes from its extensive clinical evidence, with over 80 peer-reviewed studies and 15 randomized controlled trials validating its automated CBT platform. They also have significant scale through partnerships with payers and employers, covering over 15 million lives.
Technology Stack
While specific proprietary details are not fully public, Big Health's digital therapeutics are delivered via web and mobile platforms. The broader healthcare technology landscape, which Big Health operates within, heavily utilizes cloud infrastructure (like AWS, Azure, Google Cloud) for scalability, data management, AI, and EHR integrations.
Physician Tip

For physicians, Big Health stands out due to its strong emphasis on clinical evidence and validated outcomes. Their digital therapeutics, such as Sleepio and Daylight, are backed by numerous peer-reviewed studies and randomized controlled trials, offering safe and effective non-drug alternatives for common mental health conditions like insomnia, anxiety, and depression. The programs are designed by leading clinical experts and deliver gold-standard care, specifically Cognitive Behavioral Therapy (CBT), in an accessible and scalable format. This can be particularly beneficial for addressing long waiting times for traditional CBT. The expansion into adolescent mental health with SparkRx also provides much-needed evidence-based options for younger patients. Physicians can trust Big Health's offerings as clinically validated tools that can complement existing treatment plans and improve patient access to care.

Big Health's integration with payers and employers is a significant aspect of its distribution, providing reimbursed access to over 12 million people globally. They also aim to deepen PBM/insurer integrations and explore API integrations with 'super-platforms' and device makers. The broader healthcare technology stack often involves integrations with Electronic Health Records (EHRs) and utilizes cloud platforms (AWS, Azure, Google Cloud) which support various healthcare data exchanges and interoperability standards like FHIR. This suggests a strategic direction towards seamless integration within the wider healthcare ecosystem.

Products by Big Health

1 product in the directory

Daylight
Big Health
Mental & Behavioral Health AI
Daylight is a digital care program for worry and anxiety—available anytime, anywhere. It offers tailored support and helps users track their progress with day-to-day practices and techniques for meaningful behavior change.

What the Web Says

Big Health offers digital therapeutics for mental health conditions like insomnia and anxiety, with a focus on providing accessible and effective non-drug alternatives. Their programs, such as Sleepio and Daylight, utilize cognitive and behavioral techniques. The company emphasizes a positive work culture with collaborative and empathetic teams, and opportunities for professional development.

Overall: Mixed

Strengths

  • Accessible and effective digital mental health solutions.
  • Strong focus on evidence-based approaches with peer-reviewed publications.
  • Positive work environment with supportive colleagues and leadership.
  • Good compensation and benefits for employees, including 401(k) matching and generous PTO.
  • Opportunities for professional development and internal growth.
  • Flexible work arrangements, including remote work capabilities.

Limitations

  • Limited information available on product-specific reviews from independent sources like G2, Capterra, or Reddit.
  • Some general concerns about management and leadership in broader healthcare IT contexts, which may or may not apply to Big Health.
  • Potential for micromanagement in some departments within larger healthcare organizations (general observation, not specific to Big Health).
  • Lack of detailed, unbiased product reviews from major platforms makes it difficult to assess user satisfaction comprehensively.
  • The company's Comparably ratings, while positive, are based on a small number of employee reviews.
  • General challenges in healthcare IT regarding budget cuts and overworked staff are common in the industry.

Based on reviews from: Comparably, Big Health Website, Reddit, G2, Indeed, Capterra

Last updated: 2026-06-20

Videos

News, demos, and interviews about Big Health.

Loading videos...

Videos load interactively. If none appear, search YouTube for Big Health →

View all on YouTube

Press & Coverage

Big Health
Big Health Secures Funding to Accelerate Adoption of Digital Mental Health Treatments
Big Health announced a $23.7 million strategic funding round to accelerate access to its FDA-cleared digital therapeutics, SleepioRx and DaylightRx, following new CMS billing codes for digital mental health treatments. This investment aims to expand adoption by health systems and leverage the new national Medicare coverage for these solutions.
2026-02
Big Health
New JAMA Study Showcases Clinical Benefits of SleepioRx in Patients with Comorbid Insomnia and Depression Symptoms, Marking 100+ Peer-Reviewed Papers for Big Health
Big Health announced a new JAMA study demonstrating the clinical benefits of SleepioRx for patients with comorbid insomnia and depression symptoms, marking over 100 peer-reviewed publications for the company. The study highlights the effectiveness of their FDA-cleared digital insomnia treatment.
2025-03
Big Health
FDA-Cleared Digital Treatments are Shaping the Future of Mental Healthcare
This article discusses how FDA-cleared digital mental health treatments like Big Health's SleepioRx and DaylightRx are transforming mental healthcare. It highlights the impact of FDA clearance and Medicare reimbursement through new CMS codes on the broad adoption of these effective and accessible treatments.
2025-03
Big Health
US FDA Grants Clearance for DaylightRx
The U.S. FDA granted clearance for DaylightRx, Big Health's digital therapeutic for generalized anxiety disorder, making it the first FDA-cleared non-drug treatment for this condition and the company's second FDA clearance. This expands Big Health's portfolio of evidence-based digital mental health solutions.
2024-09
PR Newswire
U.S. Food and Drug Administration Grants Clearance for Big Health's SleepioRx
Big Health received FDA clearance for SleepioRx, its flagship digital therapeutic for chronic insomnia/insomnia disorder, intended as an adjunct to usual care for adults 18 and older. This clearance allows SleepioRx to be available as a prescription device by licensed healthcare providers.
2024-08
American Psychological Association
A major step forward in using digital treatments to extend care
This article highlights the FDA clearance of Big Health's SleepioRx and DaylightRx, along with proposed CMS reimbursement codes for mental health digital therapeutics. These developments are seen as a significant advancement in extending evidence-based mental health care through technology.
2024-09
MTS Health Partners
Big Health Expands into Adolescent Mental Health Through Acquisition of Limbix
Big Health acquired Limbix, expanding its therapeutic portfolio to include SparkRx for adolescent depression and an adolescent anxiety product in development. This acquisition addresses the youth mental health crisis by adding evidence-based digital therapeutics for teens and young adults.
2023-07
Big Health
Big Health Raises $75 Million in Series C Funding Led by SoftBank Vision Fund 2
Big Health announced a $75 million Series C funding round led by SoftBank Vision Fund 2, with participation from other investors. This funding aims to accelerate the company's commercial reimbursement model and product platform, including the development of new digital therapeutics.
2022-01

Frequently Asked Questions

Big Health offers several digital therapeutic products. SleepioRx is an FDA-cleared prescription digital therapeutic for chronic insomnia in adults. DaylightRx is an FDA-cleared prescription digital therapeutic for generalized anxiety disorder (GAD) in adults. For depression, they offer Spark Direct (formerly SparkRx), which provides cognitive behavioral therapy (CBT) techniques to improve mood, including for adolescents.
Big Health's digital therapeutics, including SleepioRx, DaylightRx, and Spark Direct, are built upon the principles of Cognitive Behavioral Therapy (CBT). These programs deliver evidence-based CBT techniques through digital platforms, helping individuals identify and address unhelpful thoughts, emotions, and behaviors associated with their conditions.
Big Health's products are backed by extensive clinical evidence, including over 100 peer-reviewed publications and 22 randomized controlled trials. For instance, up to 76% of SleepioRx patients achieve improvement in insomnia, and 71% of DaylightRx patients experience improvement in GAD. These digital treatments are designed to be engaging and interactive, promoting compliance by offering accessible, on-demand care.
Big Health's FDA-cleared digital therapeutics, SleepioRx and DaylightRx, are reimbursable under Medicare Fee-for-Service and Medicare Advantage, with new national billing codes effective January 1, 2025. Patients may have a cost-share obligation depending on their specific plan policies, similar to other covered services. Big Health also partners with health plans and employers to offer their solutions.
Big Health aims to support clinicians by providing accessible, non-drug programs that can complement existing care methods or serve as primary treatments. They emphasize seamless integration into clinical workflows and offer resources to help clinicians incorporate these validated treatments into patient care plans.
Big Health has established strategic partnerships with major healthcare players, including CVS Health for reimbursement pathways and Grow Therapy for integrating their programs with a provider network. They also partner with health systems like Henry Ford and Northwell, and have an exclusive partnership with the American Psychological Association (APA) to advance education on digital treatments.
Big Health is positioned as a leader in clinically validated digital therapeutics, backed by significant investor funding, including a $23.7 million strategic round in February 2026, and a total of $153 million raised across five funding rounds. The company's stability is supported by its FDA-cleared products and new reimbursement pathways, though growth is dependent on payer adoption and clinical workflow integration.

Investors

Who's funded Big Health.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.